4//SEC Filing
Park Sangwoo 4
Accession 0001209191-23-058901
CIK 0001845459other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 9:02 PM ET
Size
8.1 KB
Accession
0001209191-23-058901
Insider Transaction Report
Form 4
Park Sangwoo
Director10% OwnerOther
Transactions
- Gift
Common Stock
2023-12-13−2,500,000→ 10,120,612 total(indirect: See footnotes)
Holdings
- 397,378
Common Stock
NKMAX Co., Ltd.
10% Owner
Transactions
- Gift
Common Stock
2023-12-13−2,500,000→ 10,120,612 total(indirect: See footnotes)
Holdings
- 397,378
Common Stock
Footnotes (3)
- [F1]This statement is filed by NKMax Co., Ltd ("NKMax") and Sangwoo Park ("Mr. Park"). The foregoing persons are hereinafter sometimes referred to as the "Reporting Persons." Mr. Park may be deemed to beneficially own the reported securities by virtue of the fact that Mr. Park has voting and dispositive control over the Issuer's securities held by NKMax.
- [F2]The filing of this statement should not be construed as an admission that Mr. Park is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities held by NKMax except to the extent of his pecuniary interest therein.
- [F3]These shares are owned directly by Sangwoo Park.
Documents
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeother
Related Parties
1- filerCIK 0001991118
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 9:02 PM ET
- Size
- 8.1 KB